10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $316,342 | -9.6% | 5,653 | -33.4% | 0.23% | -15.2% |
| Q3 2023 | $350,089 | -41.9% | 8,487 | -21.4% | 0.27% | -32.1% |
| Q2 2023 | $602,960 | +4.3% | 10,798 | +4.2% | 0.40% | -2.2% |
| Q1 2023 | $578,096 | +48.2% | 10,362 | -3.2% | 0.40% | +25.0% |
| Q4 2022 | $390,000 | +39.3% | 10,707 | +9.1% | 0.32% | +36.7% |
| Q3 2022 | $280,000 | -46.2% | 9,817 | -14.6% | 0.24% | +99.2% |
| Q2 2022 | $520,000 | -14.6% | 11,493 | +43.6% | 0.12% | -71.0% |
| Q1 2022 | $609,000 | -41.2% | 8,001 | +15.1% | 0.41% | -41.3% |
| Q4 2021 | $1,036,000 | +13.2% | 6,952 | +10.6% | 0.70% | +10.8% |
| Q3 2021 | $915,000 | -13.8% | 6,288 | +15.9% | 0.63% | -12.6% |
| Q2 2021 | $1,062,000 | +305.3% | 5,425 | +274.7% | 0.72% | +179.2% |
| Q1 2021 | $262,000 | – | 1,448 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |